Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06339151
Other study ID # TUH multiple dexamethasone TKA
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 23, 2024
Est. completion date October 31, 2025

Study information

Verified date March 2024
Source Thammasat University Hospital
Contact Yot Tanariyakul, M.D.
Phone 6683930257
Email y.tanariyakul@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to investigate the efficacy of single dose and double dose of dexamethasone after primary total knee replacement. The main question[s] it aims to answer [is/are]: Does 24 hours-interval of double dose of dexamethasone have better analgesic effect than single dose and 12 hours interval of double dose of dexamethasone after primary total joint replacement? Researchers will compare double dose of dexamethasone group to see if [insert effects]. Participants will [describe the main tasks participants will be asked to do, interventions they'll be given and use bullets if it is more than 2 items].


Description:

1. Randomized patients into 3 groups - Group 1: Patients received only Dexamethasone 0.15 mg/kg IV before surgery. - Group 2: Patients received Dexamethasone 0.15 mg/kg IV before surgery and Dexamethasone 0.15 mg/kg at 12 hours after surgery. - Group 3: Patients received Dexamethasone 0.15 mg/kg before surgery along and Dexamethasone 0.15 mg/kg at 24 hours after surgery. 2. Preemptive analgesia Alprazolam 0.5 mg. 1 tablet, Pregabalin 75 mg. 1 tablet before bedtime Celecoxib 400 mg. 1 tablet, Omeprazole 20 mg 1 mg tablet, Paracetamol 500 mg 2 tablets and 1 Ondansetron 4 mg 1 tablet at 1 hour before surgery. 3. The researcher will give an injection. Dexamethasone 0.15 mg/kg injection form together with Cefazolin 1 gm injection form by the anesthesiologist 30 minutes before surgery. 4. Spinal Anesthesia by an anesthesiologist before surgery The anesthetic component consists of 0.5% Bupivacaine 15 mg, which does not contain morphine, along with local anesthesia in the thigh area (Adductor canal block) with a mixture of 0.5% Bupivacaine 15 mg. 5. All patients will undergo knee replacement surgery in the same manner 6. Periarticular cocktail injection The drug contains Tranexamic acid 10 mg/kg, Morphine 5 mg, Adrenaline 0.5 mg, 5% Bupivacaine 200 mg (Marcaine 1 amp), Ketorolac 30 mg (1 amp) mixed with saline (Normal saline) until 75 ml of area is obtained. The injection site is placed around the knee joint and knee capsule. 7. After surgery, the patient will stay in the recovery room for 2 hours to take care of their symptoms. 8. Pain relievers after surgery include - Parecoxib (Dynastat) 40 mg injection every 12 hours for the first 2 days after knee replacement surgery, then change the medicine to Celecoxib 400 mg. 1 tablet after breakfast - Paracetamol 500 mg. 2 tablets every 6 hours for the first 2 days after knee replacement surgery. After that, give Paracetamol 500 mg. 2 tablets pro for pain every 6 hours - Pregabalin 75 mg. 1 tablet po hs - Morphine 3 mg injection every 4 hours for patients with a pain score greater than 4 points (VAS-P score ≥4) - Ondansetron 4 mg IV prn for nausea and vomitting every 6 hours - Alprazolam 0.5 mg 1 tab po hs - Cefazolin 1 gm IV every 6 hours for the first 24 hours after surgery 9. Group 2 patients will receive Dexamethasone 0.15 mg/kg as an injection after surgery at 12 hours, and patients in Group 3 will receive Dexamethasone 0.15 mg/kg as injection at 24 hours after surgery


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date October 31, 2025
Est. primary completion date October 31, 2025
Accepts healthy volunteers No
Gender All
Age group 50 Years to 85 Years
Eligibility Inclusion Criteria: - Diagnosis of primary osteoarthritis of knee joint - Undergo unilateral primary total knee replacement - Age between 50-85 years old Exclusion Criteria: - Allergy to dexamethasone - History of long term corticosteroid used - New York heart association (NYHA) class > II - Type 2 Diabetes mellitus that had HbA1c > 7 % or FBS > 200 mg/dl - Chronic kidney disease > stage III or eGFR < 60 - Cirrhosis Child class B or C - Cannot use pain controlled as protocol - History of previous knee surgery - History of previous septic arthritis at knee joint

Study Design


Intervention

Drug:
Dexamethasone before surgery
Dexamethasone 0.15 mg/kg IV before surgery
Dexamethasone before and 12 hours after surgery
Dexamethasone 0.15 mg/kg IV before surgery Dexamethasone 0.15 mg/kg IV at 12 hours post operation
Dexamethasone before and 24 hours after surgery
Dexamethasone 0.15 mg/kg IV before surgery Dexamethasone 0.15 mg/kg IV at 24 hours post operation

Locations

Country Name City State
Thailand Thammasat University Hospital Khlong Luang Pathum Thani

Sponsors (1)

Lead Sponsor Collaborator
Thammasat University Hospital

Country where clinical trial is conducted

Thailand, 

References & Publications (1)

Xu H, Zhang S, Xie J, Lei Y, Cao G, Pei F. Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study. J Arthroplasty. 2018 Nov;33(11):3448-3454. doi: 10.1016/j.arth.2018.06.031. Epub 2018 Jul 4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain at rest and motion Using visual analog scale 0-10 (0 means best, 10 means worst) At 6 hour, 12 hour, 18 hour, 24 hour, 30 hour, 36 hour, 42 hour, 48 hour, 54 hour, 60 hour, 66 hour and 72 hour after surgery
Secondary Nausea and vomiting Using visual analog scale 0-10 (0 means best, 10 means worst) At 24 hour, 48 hour and 72 hour after surgery
Secondary Morphine consumption Total milligrams use of morphine postoperative (record in mg) At 24 hour, 48 hour and 72 hour after surgery
Secondary Blood sugar level record in mg/dL At 24 hour and 48 hour after surgery
Secondary CRP level record in mg/dL At 24 hour and 48 hour after surgery
Secondary Range of motion Using long arm goniometer (record in degrees) At 24 hour and 48 hour after surgery
Secondary Length of hospital stay Number of days the patient stays for surgery up to 1 week
Secondary Complication Surgical site infection, deep infection or wound complication up to 6 months
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Terminated NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2